Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
On December 22, 2021, Teva launched an AB-rated generic version of Emergent BioSolutions’ Narcan (naloxone) 4 mg nasal spray.
Download PDF
Return to publications
